Sociodemographic and geospatial associations with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in a large Canadian city: an 11 year retrospective study

被引:14
|
作者
Gill, Victoria C. [1 ]
Ma, Irene [2 ]
Guo, Maggie [2 ,6 ]
Gregson, Dan B. [2 ,3 ,6 ]
Naugler, Christopher [2 ,4 ,5 ,6 ]
Church, Deirdre L. [2 ,3 ,6 ]
机构
[1] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England
[2] Univ Calgary, Dept Pathol & Lab Med, Cumming Sch Med, 3535 Res Rd NW, Calgary, AB T2L 218, Canada
[3] Univ Calgary, Cumming Sch Med, Dept Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada
[4] Univ Calgary, Cumming Sch Med, Dept Family Medicne, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada
[5] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada
[6] Alberta Publ Labs, 3535 Res Rd NW, Calgary, AB T2L 2K8, Canada
基金
加拿大健康研究院;
关键词
CA-MRSA; CMRSA10; Geospatial analysis; Laboratory medicine; MOLECULAR EPIDEMIOLOGY; EMERGENCE; ALBERTA; DISEASE; USA300;
D O I
10.1186/s12889-019-7169-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The first Canadian outbreak of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) was identified in 2004 in Calgary, Alberta. Using a novel model of MRSA population-based surveillance, sociodemographic risk associations, yearly geospatial dissemination and prevalence of CA-MRSA infections over an 11year period was identified in an urban healthcare jurisdiction of Calgary. Methods: Positive MRSA case records, patient demographics and laboratory data were obtained from a centralized Laboratory Information System of Calgary Laboratory Services in Calgary, Alberta, Canada between 2004 and 2014. Public census data was obtained from Statistics Canada, which was used to match with laboratory data and mapped using Geographic Information Systems. Results: During the study period, 52.5% of positive MRSA infections in Calgary were CA-MRSA cases. The majority were CMRSA10 (USA300) clones (94.1%; n=4255), while the remaining case (n=266) were CMRSA7 (USA400) clones. Period prevalence of CMRSA10 increased from 3.6 cases/100000 population in 2004, to 41.3 cases/100000 population in 2014. Geospatial analysis demonstrated wide dissemination of CMRSA10 annually in the city. Those who are English speaking (RR=0.05, p<0.0001), identify as visible minority Chinese (RR=0.09, p=0.0023) or visible minority South Asian (RR=0.25, p=0.015), and have a high median household income (RR=0.27, p<0.0001) have a significantly decreased relative risk of CMRSA10 infections. Conclusions: CMRSA10 prevalence increased between 2004 and 2007, followed by a stabilization of cases by 2014. Certain sociodemographic factors were protective from CMRSA10 infections. The model of MRSA population-surveillance and geomap outbreak events can be used to track the epidemiology of MRSA in any jurisdiction.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Sociodemographic and geospatial associations with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in a large Canadian city: an 11 year retrospective study
    Victoria C. Gill
    Irene Ma
    Maggie Guo
    Dan B. Gregson
    Christopher Naugler
    Deirdre L. Church
    BMC Public Health, 19
  • [2] Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections
    Odell, Christine A.
    CURRENT OPINION IN PEDIATRICS, 2010, 22 (03) : 273 - 277
  • [3] The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
    Lee, B. Y.
    Singh, A.
    David, M. Z.
    Bartsch, S. M.
    Slayton, R. B.
    Huang, S. S.
    Zimmer, S. M.
    Potter, M. A.
    Macal, C. M.
    Lauderdale, D. S.
    Miller, L. G.
    Daum, R. S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (06) : 528 - 536
  • [4] Community-Associated Methicillin Resistant Staphylococcus aureus Pneumonia (CA-MRSA)
    Mazo, Marcela
    Stupka, John E.
    Mortensen, Eric M.
    Anzueto, Antonio
    Restrepo, Marcos I.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (03) : 194 - 200
  • [5] Emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in Southeast Austria
    Grisold, A. J.
    Zarfel, G.
    Stoeger, A.
    Feierl, G.
    Raggam, R. B.
    Marth, E.
    JOURNAL OF INFECTION, 2009, 58 (02) : 168 - 170
  • [6] Clinical outcomes and treatment approach for community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in Israel
    Berla-Kerzhner, E.
    Biber, A.
    Parizade, M.
    Taran, D.
    Rahav, G.
    Regev-Yochay, G.
    Glikman, D.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (01) : 153 - 162
  • [7] Clinical outcomes and treatment approach for community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in Israel
    E. Berla-Kerzhner
    A. Biber
    M. Parizade
    D. Taran
    G. Rahav
    G. Regev-Yochay
    D. Glikman
    European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36 : 153 - 162
  • [8] Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) clones from Paraguayan children
    Rodriguez, Fatima
    Salinas, Claudia
    Fernandez, Silvina
    Haim, Sol
    Mollerach, Marta
    Basualdo, Wilma
    Castro, Hector
    Quinonez, Beatriz
    Arguello, Rocio
    Rodriguez, Monica
    Grau, Lorena
    Espinola, Carmen
    Velazquez, Gladys
    Samudio, Gloria
    Gomez, Gloria
    Campuzano, Ana
    Ortellado, Juana
    Almada, Patricia
    Guillen, Rosa
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2020, 14 (03): : 290 - 297
  • [9] Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA)
    Mediavilla, Jose R.
    Chen, Liang
    Mathema, Barun
    Kreiswirth, Barry N.
    CURRENT OPINION IN MICROBIOLOGY, 2012, 15 (05) : 588 - 595
  • [10] Puerperal mastitis caused by limited community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) clones
    Lin, Yu-Cheng
    Lee, Yu-Lin
    Chen, Yi-Hsin
    Tsao, Shih-Ming
    Wang, Wei-Yao
    FRONTIERS IN MEDICINE, 2024, 11